Timothy E. Baxter
Known title: DirectorCIK: 0001914275
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
PAVmed Included in List of Moving Health Care Stocks. PAVmed was featured in a Benzinga article highlighting health care stocks with notable intraday movement on Thursday. The stock is currently trading near its 52-week low, with technical indicators showing oversold conditions and a recent breakdown below support levels. This inclusion reflects current market attention to the stock's price action rather than a specific corporate announcement.
Transaction History
| IONQ | ▲ Buy | Grant | 5,540 | $0 | 8/24/2026 | View on chart |
| PAVM | ▲ Buy | Grant | 13,930 | $0 | 4/2/2026 | View on chart |
| PAVM | ▲ Buy | Grant | 150,000 | $0 | 9/30/2025 | View on chart |
| PAVM | ▲ Buy | Grant | 65,000 | — | 2/22/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
IonQ: Quantum Sector Momentum vs. Fundamentals Debate
Recent coverage focuses on whether the quantum computing rally is driven by real progress or just market momentum. Articles compare IonQ to peers like Rigetti and Alphabet, highlighting how AI and supercomputing integration may give IonQ an edge. While the stock has seen recent gains, analysts continue to debate if current valuations match the company's fundamental growth.
IonQ: Quantum Sector Momentum vs. Fundamentals Debate. Recent coverage focuses on whether the quantum computing rally is driven by real progress or just market momentum. Articles compare IonQ to peers like Rigetti and Alphabet, highlighting how AI and supercomputing integration may give IonQ an edge. While the stock has seen recent gains, analysts continue to debate if current valuations match the company's fundamental growth.